Back

Bullish Case: FDA's accelerated approval of Amtagvi heralds Iovance's transition to commercial stage, with high demand and further market penetration expected in melanoma treatment.


Bearish Case: Despite FDA approval, missed earnings and market saturation concerns may limit IOVA's upside, with potential overvaluation based on aggressive growth assumptions.


Potential Outcomes:

1) Robust Amtagvi sales drive stock growth (40%).

2) Earnings disappointments trigger sell-offs (30%).

3) Regulatory hurdles in new markets impact sentiment (30%).


Trading Oracle: Sign Up to access trading oracle trade ideas.


April 02, 2024


Iovance Biotherapeutics Forecast

IOVA        Iovance Biotherapeutics
Price Forecast: NEUTRAL    Price Action: RANDOM (?)











Correlated Stock Forecasts

Assets that tend to move strongly with IOVA



XBI Forecast + Options Trading Strategies   XBI  SPDR Biotech (0.95)


LQDA Forecast + Options Trading Strategies   LQDA  Liquidia (0.94)


CLDX Forecast + Options Trading Strategies   CLDX  Celldex Therapeutics (0.92)


SLM Forecast + Options Trading Strategies   SLM  SLM (0.91)


BOTZ Forecast + Options Trading Strategies   BOTZ  Global X Funds Global X Robotics & Artificial Intelli (0.9)



Uncorrelated Stock Forecasts

Assets with little price relationship to IOVA



FIVN Forecast + Options Trading Strategies   FIVN  Five9 (-0.0)


PRGO Forecast + Options Trading Strategies   PRGO  Perrigo (-0.0)


FTDR Forecast + Options Trading Strategies   FTDR  Frontdoor (0.0)


GLBE Forecast + Options Trading Strategies   GLBE  Global E Online (-0.01)


NOK Forecast + Options Trading Strategies   NOK  Nokia (-0.01)



Anticorrelated Stock Forecasts

Assets that tend to move strongly against IOVA



SRS Forecast + Options Trading Strategies   SRS  ProShares UltraShort Real Estate (-0.76)


TZA Forecast + Options Trading Strategies   TZA  Direxion Daily Small Cap Bear 3X Shares (-0.8)


SRTY Forecast + Options Trading Strategies   SRTY  ProShares UltraPro Short Russell2000 (-0.8)


RWM Forecast + Options Trading Strategies   RWM  ProShares Trust - ProShares Short Russell2000 (-0.81)


EQNR Forecast + Options Trading Strategies   EQNR  Equinor ASA - (-0.81)





Become a more profitable investor with AI optimized trading strategies






×

Chat with IOVA


 Ask me any question!